US 12173021
Treprostinil prodrugs
granted A61KA61K45/06A61K9/0019
Quick answer
US patent 12173021 (Treprostinil prodrugs) held by United Therapeutics Corporation expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United Therapeutics Corporation
- Grant date
- Tue Dec 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K45/06, A61K9/0019, A61K9/0053, A61P